Merck
Worldwide
   

 

About this Study
Condition Intervention Phase
Human Immunodeficiency Virus Drug: MK-0518 Phase III

ENROLLMENT IN THIS STUDY IS CLOSED.
QDMRK
About Enrolling
 
You may be eligible for the study if you:
  • Are HIV positive with viral load greater than 5,000.
  • Have never taken medication to treat your HIV.
  • Are 18 years of age or older.
Participation in this study includes at no cost:
  • Study-related doctor visits
  • Investigational study drug
  • Laboratory testing
  • In many cases, reimbursement for transportation and childcare will be available.
PrintPrintable Version

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.

Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)